Cindy R. Tahl

2020

In 2020, Cindy R. Tahl earned a total compensation of $2.5M as General Counsel and Corporate Secretary at Fate Therapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$195,000
Option Awards$1,324,347
Salary$390,000
Stock Awards$549,750
Total$2,459,097

Tahl received $1.3M in option awards, accounting for 54% of the total pay in 2020.

Tahl also received $195K in non-equity incentive plan, $390K in salary and $549.8K in stock awards.

Rankings

In 2020, Cindy R. Tahl's compensation ranked 4,625th out of 13,090 executives tracked by ExecPay. In other words, Tahl earned more than 64.7% of executives.

ClassificationRankingPercentile
All
4,625
out of 13,090
65th
Division
Manufacturing
1,881
out of 5,617
67th
Major group
Chemicals And Allied Products
735
out of 2,248
67th
Industry group
Drugs
630
out of 1,948
68th
Industry
Biological Products, Except Diagnostic Substances
148
out of 411
64th
Source: SEC filing on April 21, 2021.

Tahl's colleagues

We found four more compensation records of executives who worked with Cindy R. Tahl at Fate Therapeutics in 2020.

2020

Edward Dulac

Fate Therapeutics

Chief Financial Officer

2020

J Wolchko

Fate Therapeutics

Chief Executive Officer

2020

Bahram Valamehr

Fate Therapeutics

Chief Research and Development Officer

2020

Daniel Shoemaker

Fate Therapeutics

Chief Scientific Officer

News

In-depth

You may also like